50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,645.12 (-1.99%)
DOW   29,208.24 (-1.60%)
QQQ   273.09 (-2.45%)
AAPL   144.36 (-3.66%)
MSFT   236.93 (-1.72%)
META   137.92 (-2.61%)
GOOGL   97.15 (-2.90%)
AMZN   114.90 (-2.64%)
TSLA   278.16 (-3.35%)
NVDA   122.80 (-3.58%)
NIO   16.58 (-4.33%)
BABA   78.31 (-3.31%)
AMD   65.51 (-4.17%)
T   15.54 (-1.83%)
MU   49.44 (-3.06%)
CGC   2.88 (-5.26%)
F   11.48 (-5.75%)
GE   62.61 (-2.87%)
DIS   96.97 (-2.44%)
AMC   7.27 (-5.22%)
PYPL   89.56 (-1.71%)
PFE   44.18 (-0.56%)
NFLX   239.98 (-2.13%)
S&P 500   3,645.12 (-1.99%)
DOW   29,208.24 (-1.60%)
QQQ   273.09 (-2.45%)
AAPL   144.36 (-3.66%)
MSFT   236.93 (-1.72%)
META   137.92 (-2.61%)
GOOGL   97.15 (-2.90%)
AMZN   114.90 (-2.64%)
TSLA   278.16 (-3.35%)
NVDA   122.80 (-3.58%)
NIO   16.58 (-4.33%)
BABA   78.31 (-3.31%)
AMD   65.51 (-4.17%)
T   15.54 (-1.83%)
MU   49.44 (-3.06%)
CGC   2.88 (-5.26%)
F   11.48 (-5.75%)
GE   62.61 (-2.87%)
DIS   96.97 (-2.44%)
AMC   7.27 (-5.22%)
PYPL   89.56 (-1.71%)
PFE   44.18 (-0.56%)
NFLX   239.98 (-2.13%)
S&P 500   3,645.12 (-1.99%)
DOW   29,208.24 (-1.60%)
QQQ   273.09 (-2.45%)
AAPL   144.36 (-3.66%)
MSFT   236.93 (-1.72%)
META   137.92 (-2.61%)
GOOGL   97.15 (-2.90%)
AMZN   114.90 (-2.64%)
TSLA   278.16 (-3.35%)
NVDA   122.80 (-3.58%)
NIO   16.58 (-4.33%)
BABA   78.31 (-3.31%)
AMD   65.51 (-4.17%)
T   15.54 (-1.83%)
MU   49.44 (-3.06%)
CGC   2.88 (-5.26%)
F   11.48 (-5.75%)
GE   62.61 (-2.87%)
DIS   96.97 (-2.44%)
AMC   7.27 (-5.22%)
PYPL   89.56 (-1.71%)
PFE   44.18 (-0.56%)
NFLX   239.98 (-2.13%)
S&P 500   3,645.12 (-1.99%)
DOW   29,208.24 (-1.60%)
QQQ   273.09 (-2.45%)
AAPL   144.36 (-3.66%)
MSFT   236.93 (-1.72%)
META   137.92 (-2.61%)
GOOGL   97.15 (-2.90%)
AMZN   114.90 (-2.64%)
TSLA   278.16 (-3.35%)
NVDA   122.80 (-3.58%)
NIO   16.58 (-4.33%)
BABA   78.31 (-3.31%)
AMD   65.51 (-4.17%)
T   15.54 (-1.83%)
MU   49.44 (-3.06%)
CGC   2.88 (-5.26%)
F   11.48 (-5.75%)
GE   62.61 (-2.87%)
DIS   96.97 (-2.44%)
AMC   7.27 (-5.22%)
PYPL   89.56 (-1.71%)
PFE   44.18 (-0.56%)
NFLX   239.98 (-2.13%)
NASDAQ:KURA

Kura Oncology - KURA Stock Forecast, Price & News

$13.31
-0.12 (-0.89%)
(As of 09/29/2022 09:42 AM ET)
Add
Compare
Today's Range
$13.25
$13.54
50-Day Range
$12.01
$16.50
52-Week Range
$10.41
$19.96
Volume
1,037 shs
Average Volume
886,049 shs
Market Capitalization
$890.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$37.50

Kura Oncology MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
179.2% Upside
$37.50 Price Target
Short Interest
Bearish
12.79% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.76
Upright™ Environmental Score
News Sentiment
0.70mentions of Kura Oncology in the last 14 days
Based on 14 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($2.18) to ($2.54) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.92 out of 5 stars

Medical Sector

779th out of 1,096 stocks

Pharmaceutical Preparations Industry

379th out of 548 stocks

KURA stock logo

About Kura Oncology (NASDAQ:KURA) Stock

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications. The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California.

Receive KURA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kura Oncology and its competitors with MarketBeat's FREE daily newsletter.

KURA Stock News Headlines

Analysts Set Kura Oncology, Inc. (NASDAQ:KURA) Target Price at $38.57
Kura Oncology
Biden Warns America on China: "They're Going to Eat Our Lunch"
A new cold war over "white gold" is unfolding. This affects every cell phone, laptop… even tools in your home. But one small company is poised to break the Chinese stranglehold and reward savvy investors.
Biden Warns America on China: "They're Going to Eat Our Lunch"
A new cold war over "white gold" is unfolding. This affects every cell phone, laptop… even tools in your home. But one small company is poised to break the Chinese stranglehold and reward savvy investors.
Earnings Preview: Kura Oncology
Kura Oncology Stock Scores Rising Relative Strength
Kura Oncology Q1 2022 Earnings Preview
See More Headlines
Receive KURA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kura Oncology and its competitors with MarketBeat's FREE daily newsletter.

KURA Company Calendar

Last Earnings
8/03/2022
Today
9/29/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:KURA
Fax
N/A
Employees
121
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$37.50
High Stock Price Forecast
$80.00
Low Stock Price Forecast
$26.00
Forecasted Upside/Downside
+181.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
7 Analysts

Profitability

Net Income
$-130,470,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$7.61 per share

Miscellaneous

Free Float
63,281,000
Market Cap
$890.31 million
Optionable
Optionable
Beta
0.93

Key Executives

  • Dr. Troy Edward Wilson J.D. (Age 53)
    Ph.D., Chairman, CEO, Pres & Principal Financial Officer
    Comp: $984.61k
  • Ms. Kathleen Ford (Age 75)
    Chief Operating Officer
    Comp: $689.32k
  • Dr. Marc Grasso M.D. (Age 48)
    Advisor
    Comp: $651.68k
  • Ms. Kirsten Flowers (Age 47)
    Chief Commercial Officer & Chief Corp. Strategy Officer
    Comp: $642.98k
  • Dr. Stephen Dale M.D. (Age 50)
    Chief Medical Officer
    Comp: $811.58k
  • Mr. Thomas Doyle (Age 51)
    Principal Accounting Officer & Sr. VP of Fin. and Accounting
  • Mr. Pete De Spain
    Sr. VP of Investor Relations & Corp. Communications
  • Ms. Teresa Brophy Bair Esq. (Age 51)
    J.D., Chief Legal Officer & Corp. Sec.
  • Mr. James E. Basta J.D. (Age 56)
    Esq., Chief Compliance Officer & Corp. Sec.
  • Dr. Roger Bakale Ph.D.
    VP and Head of CMC, Clinical & Commercial Manufacturing













KURA Stock - Frequently Asked Questions

Should I buy or sell Kura Oncology stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Kura Oncology in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" KURA shares.
View KURA analyst ratings
or view top-rated stocks.

What is Kura Oncology's stock price forecast for 2022?

7 brokerages have issued twelve-month target prices for Kura Oncology's shares. Their KURA share price forecasts range from $26.00 to $80.00. On average, they predict the company's share price to reach $37.50 in the next twelve months. This suggests a possible upside of 179.2% from the stock's current price.
View analysts price targets for KURA
or view top-rated stocks among Wall Street analysts.

How have KURA shares performed in 2022?

Kura Oncology's stock was trading at $14.00 at the beginning of the year. Since then, KURA shares have decreased by 4.1% and is now trading at $13.43.
View the best growth stocks for 2022 here
.

When is Kura Oncology's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our KURA earnings forecast
.

How were Kura Oncology's earnings last quarter?

Kura Oncology, Inc. (NASDAQ:KURA) announced its quarterly earnings data on Wednesday, August, 3rd. The company reported ($0.52) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.52).

What other stocks do shareholders of Kura Oncology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kura Oncology investors own include Exelixis (EXEL), Inovio Pharmaceuticals (INO), Viking Therapeutics (VKTX), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Amarin (AMRN), Gilead Sciences (GILD), NVIDIA (NVDA), Corbus Pharmaceuticals (CRBP) and Advanced Micro Devices (AMD).

What is Kura Oncology's stock symbol?

Kura Oncology trades on the NASDAQ under the ticker symbol "KURA."

Who are Kura Oncology's major shareholders?

Kura Oncology's stock is owned by a number of retail and institutional investors. Top institutional investors include State Street Corp (4.53%), Deerfield Management Company L.P. Series C (3.93%), Commodore Capital LP (2.73%), Assenagon Asset Management S.A. (1.74%), Goldman Sachs Group Inc. (1.44%) and Affinity Asset Advisors LLC (1.39%). Insiders that own company stock include Kathleen Ford, Marc Grasso and Troy Edward Wilson.
View institutional ownership trends
.

How do I buy shares of Kura Oncology?

Shares of KURA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Kura Oncology's stock price today?

One share of KURA stock can currently be purchased for approximately $13.43.

How much money does Kura Oncology make?

Kura Oncology (NASDAQ:KURA) has a market capitalization of $898.37 million. The company earns $-130,470,000.00 in net income (profit) each year or ($2.00) on an earnings per share basis.

How many employees does Kura Oncology have?

The company employs 121 workers across the globe.

How can I contact Kura Oncology?

Kura Oncology's mailing address is 12730 HIGH BLUFF DRIVE SUITE 400, SAN DIEGO CA, 92130. The official website for the company is www.kuraoncology.com. The company can be reached via phone at (858) 500-8800 or via email at ir@kuraoncology.com.

This page (NASDAQ:KURA) was last updated on 9/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.